Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EV/Core EBITDA

    Back to All Ratios
BLISS GVS PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 6.725.865.464.847.72

What is the latest EV/Core EBITDA ratio of BLISS GVS PHARMA ?

The latest EV/Core EBITDA ratio of BLISS GVS PHARMA is 6.72 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20256.72
Mar20245.86
Mar20235.46
Mar20224.84
Mar20217.72

How is EV/Core EBITDA of BLISS GVS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 6.72
14.68
Mar2024 5.86
7.33
Mar2023 5.46
12.81
Mar2022 4.84
-37.31
Mar2021 7.72 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EV/Core EBITDA ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,589.8 Cr -0.7% -9.6% 16.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,342.0 Cr 3.4% 1.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹164,555.0 Cr 2.4% 3.2% 11.9% Stock Analytics
CIPLA ₹127,259.0 Cr 1.8% 1.9% -5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,898.0 Cr 2.8% -0.9% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,394.0 Cr 1.7% 6.2% -0.3% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

-0.7%

-9.6%

16.7%

SENSEX

0.9%

1.2%

-0.4%


You may also like the below Video Courses